Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Judd Berman
In Vitroactivity (MICs and Rate of Kill) of AFN-1252, a Novel FabI Inhibitor, in the Presence of Serum and in Combination With Other Antibiotics
Journal of Chemotherapy
Medicine
Oncology
Infectious Diseases
Pharmacology
Related publications
OA12 a Phase I Study of Novel BCL-2/BCL-xL Inhibitor APG-1252 in Patients With Advanced SCLC or Other Solid Tumor
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Selection of Antibiotics for Tonsillitis and Combination With Other Drugs.
Practica Otologica
Otorhinolaryngology
In Vitro Activity of LY146032 Alone and in Combination With Other Antibiotics Against Gram-Positive Bacteria.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Sensitization of Staphylococcus Aureus to Methicillin and Other Antibiotics in Vitro and in Vivo in the Presence of HAMLET
PLoS ONE
Multidisciplinary
Pharmacokinetics/Pharmacodynamics of Vaborbactam, a Novel Beta-Lactamase Inhibitor, in Combination With Meropenem
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Targeting Glycolysis in Leukemia: A Novel Inhibitor 3-BrOP in Combination With Rapamycin
Leukemia Research
Cancer Research
Oncology
Hematology
Therapeutic Effect of SF-2103A, a Novel Carbapenem Antibiotic, in Combination With Cefotaxime, Cefoperazone and Other Cephalosporins.
Journal of Antibiotics
Drug Discovery
Pharmacology
In VitroActivity of AZD0914, a Novel Bacterial DNA Gyrase/Topoisomerase IV Inhibitor, Against Clinically Relevant Gram-Positive and Fastidious Gram-Negative Pathogens
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
In Vitro Activities of Rifapentine and Rifampin, Alone and in Combination With Six Other Antibiotics, Against Methicillin-Susceptible and Methicillin-Resistant Staphylococci of Different Species.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
